Figures & data
Table 1. Summary of primary renal outcome trials with an SGLT2 inhibitor.
Table 2. Summary of secondary renal outcomes observed in GLP-1RA and dual GIP/GLP-1RA trials. Adapted from [64].
Table 3. Summary of renal outcomes observed in phase 3 trials of nonsteroidal MRAs.